Authors:
SMITH LL
BOND JA
HOLBERT D
HOUMARD JA
ISRAEL RG
MCCAMMON MR
SMITH SS
Citation: Ll. Smith et al., DIFFERENTIAL WHITE CELL COUNT AFTER 2 BOUTS OF DOWNHILL RUNNING, International journal of sports medicine, 19(6), 1998, pp. 432-437
Authors:
OSTERMANGOLKAR SM
MOSS O
JAMES A
BRYANT MS
TURNER M
BOND JA
Citation: Sm. Ostermangolkar et al., EPOXYBUTENE-HEMOGLOBIN ADDUCTS IN RATS AND MICE - DOSE-RESPONSE FOR FORMATION AND PERSISTENCE DURING AND FOLLOWING LONG-TERM LOW-LEVEL EXPOSURE TO BUTADIENE, Toxicology and applied pharmacology, 150(1), 1998, pp. 166-173
Authors:
HAM J
WEBSTER J
BOND JA
JASANI B
LEWIS MD
HEPBURN PJ
DAVIES JS
LEWIS BM
THOMAS DW
SCANLON MF
Citation: J. Ham et al., IMMORTALIZED HUMAN PITUITARY-CELLS EXPRESS GLYCOPROTEIN ALPHA-SUBUNITAND THYROTROPIN-BETA (TSH-BETA), The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1598-1603
Authors:
HALLJACKSON CA
JONES T
ECCLES NG
DAWSON TP
BOND JA
GESCHER A
WYNFORDTHOMAS D
Citation: Ca. Halljackson et al., INDUCTION OF CELL-DEATH BY STIMULATION OF PROTEIN-KINASE-C IN HUMAN EPITHELIAL-CELLS EXPRESSING A MUTANT RAS ONCOGENE - A POTENTIAL THERAPEUTIC TARGET, British Journal of Cancer, 78(5), 1998, pp. 641-651
Authors:
FISCHER AH
BOND JA
TAYSAVANG P
BATTLES OE
WYNFORDTHOMAS D
Citation: Ah. Fischer et al., PAPILLARY THYROID-CARCINOMA ONCOGENE (RET PTC) ALTERS THE NUCLEAR-ENVELOPE AND CHROMATIN STRUCTURE/, The American journal of pathology, 153(5), 1998, pp. 1443-1450
Citation: Mk. Lacy et al., DEVELOPMENT OF A PATIENT-FOCUSED, INTERDISCIPLINARY ANTIMICROBIAL MANAGEMENT PROGRAM INVOLVING STAFF PHARMACISTS, American journal of health-system pharmacy, 54(16), 1997, pp. 1837-1841
Authors:
IVAN M
BOND JA
PRAT M
COMOGLIO PM
WYNFORDTHOMAS D
Citation: M. Ivan et al., ACTIVATED RAS AND RET ONCOGENES INDUCE OVER-EXPRESSION OF C-MET (HEPATOCYTE GROWTH-FACTOR RECEPTOR) IN HUMAN THYROID EPITHELIAL-CELLS, Oncogene, 14(20), 1997, pp. 2417-2423
Authors:
LEAVENS TL
FARRIS GM
JAMES RA
SHAH R
WONG VA
MARSHALL MW
BOND JA
Citation: Tl. Leavens et al., GENOTOXICITY AND CYTOTOXICITY IN MALE B6C3F1 MICE FOLLOWING EXPOSURE TO MIXTURES OF 1,3-BUTADIENE AND STYRENE, Environmental and molecular mutagenesis, 29(4), 1997, pp. 335-345
Citation: Ja. Bond et Bp. Bradley, RESISTANCE TO MALATHION IN HEAT-SHOCKED DAPHNIA-MAGNA, Environmental toxicology and chemistry, 16(4), 1997, pp. 705-712
Authors:
DORMAN DC
STRUVE MF
WONG BA
MORGAN KT
JANSZEN DB
GROSS EB
BOND JA
Citation: Dc. Dorman et al., NEUROTOXICOLOGICAL EVALUATION OF ETHYL TERTIARY-BUTYL ETHER FOLLOWINGSUBCHRONIC (90-DAY) INHALATION IN THE FISCHER-344 RAT, Journal of applied toxicology, 17(4), 1997, pp. 235-242
Authors:
SWEENEY LM
SCHLOSSER PM
MEDINSKY MA
BOND JA
Citation: Lm. Sweeney et al., PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF 1,3-BUTADIENE, 1,2-EPOXY-3-BUTENE, AND 1,2-3,4-DIEPOXYBUTANE TOXICOKINETICS IN MICE AND RATS, Carcinogenesis, 18(4), 1997, pp. 611-625
Authors:
PASTINO GM
ASGHARIAN B
ROBERTS K
MEDINSKY MA
BOND JA
Citation: Gm. Pastino et al., A COMPARISON OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL PREDICTIONS AND EXPERIMENTAL-DATA FOR INHALED ETHANOL IN MALE AND FEMALE B6C3F(1) MICE, F344 RATS, AND HUMANS, Toxicology and applied pharmacology, 145(1), 1997, pp. 147-157
Authors:
IVAN M
LUDGATE M
GIRE V
BOND JA
WYNFORDTHOMAS D
Citation: M. Ivan et al., AN AMPHOTROPIC RETROVIRAL VECTOR EXPRESSING A MUTANT GSP ONCOGENE - EFFECTS ON HUMAN THYROID-CELLS IN-VITRO, The Journal of clinical endocrinology and metabolism, 82(8), 1997, pp. 2702-2709
Authors:
WYLLIE FS
HAUGHTON MF
BOND JA
ROWSON JM
JONES CJ
WYNFORDTHOMAS D
Citation: Fs. Wyllie et al., S-PHASE CELL-CYCLE ARREST FOLLOWING DNA-DAMAGE IS INDEPENDENT OF THE P53 P21(WAF1) SIGNALING PATHWAY/, Oncogene, 12(5), 1996, pp. 1077-1082
Citation: Tl. Leavens et al., DYNAMIC INHALATION SYSTEM FOR INDIVIDUAL WHOLE-BODY EXPOSURE OF MICE TO VOLATILE ORGANIC-CHEMICALS, Inhalation toxicology, 8(7), 1996, pp. 655-677
Citation: Ja. Bond et al., THE USE OF TOXICOLOGIC DATA IN MECHANISTIC RISK ASSESSMENT - 1,3-BUTADIENE AS A CASE-STUDY, International archives of occupational and environmental health, 68(6), 1996, pp. 415-420
Authors:
BOND JA
HIMMELSTEIN MW
SEATON M
BOOGAARD P
MEDINSKY MA
Citation: Ja. Bond et al., METABOLISM OF BUTADIENE BY MICE, RATS, AND HUMANS - A COMPARISON OF PHYSIOLOGICALLY-BASED TOXICOKINETIC MODEL PREDICTIONS AND EXPERIMENTAL-DATA, Toxicology, 113(1-3), 1996, pp. 48-54
Citation: L. Recio et al., MUTAGENICITY AND MUTATIONAL SPECTRA OF 1,3-BUTADIENE IN THE BONE-MARROW OF B6C3F1 LACI TRANSGENIC MICE, Toxicology, 113(1-3), 1996, pp. 106-111
Citation: Pj. Boogaard et al., HEPATIC AND PULMONARY GLUTATHIONE CONJUGATION OF 1,2-3,4-DIEPOXYBUTANE IN HUMAN, RAT, AND MOUSE IN-VITRO, Toxicology, 113(1-3), 1996, pp. 297-299
Authors:
HIMMELSTEIN MW
TURNER MJ
ASGHARIAN B
BOND JA
Citation: Mw. Himmelstein et al., METABOLISM OF 1,3-BUTADIENE - INHALATION PHARMACOKINETICS AND TISSUE DOSIMETRY OF BUTADIENE EPOXIDES IN RATS AND MICE, Toxicology, 113(1-3), 1996, pp. 306-309
Citation: Tl. Leavens et Ja. Bond, PHARMACOKINETIC MODEL DESCRIBING THE DISPOSITION OF BUTADIENE AND STYRENE IN MICE, Toxicology, 113(1-3), 1996, pp. 310-313